Where I see patients (1)
Selected research
-
CD22 TCR-engineered T cells exert antileukemia cytotoxicity without causing inflammatory responses.
Science advances
-
Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.
JCI insight
-
Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6.
Clinical cancer research : an official journal of the American Association for Cancer Research